Clinical Trial Detail

NCT ID NCT03158883
Title Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors University of California, Davis
Indications

non-small cell lung carcinoma

Therapies

Avelumab

Age Groups: adult senior

Additional content available in CKB BOOST